GB201503720D0 - Chemical compound - Google Patents

Chemical compound

Info

Publication number
GB201503720D0
GB201503720D0 GB201503720A GB201503720A GB201503720D0 GB 201503720 D0 GB201503720 D0 GB 201503720D0 GB 201503720 A GB201503720 A GB 201503720A GB 201503720 A GB201503720 A GB 201503720A GB 201503720 D0 GB201503720 D0 GB 201503720D0
Authority
GB
United Kingdom
Prior art keywords
chemical compound
chemical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201503720A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property No 2 Ltd
Original Assignee
GlaxoSmithKline Intellectual Property No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property No 2 Ltd filed Critical GlaxoSmithKline Intellectual Property No 2 Ltd
Priority to GB201503720A priority Critical patent/GB201503720D0/en
Publication of GB201503720D0 publication Critical patent/GB201503720D0/en
Priority to TW105106561A priority patent/TW201704230A/en
Priority to PCT/EP2016/054516 priority patent/WO2016139292A1/en
Priority to ARP160100564A priority patent/AR103844A1/en
Priority to UY0001036574A priority patent/UY36574A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB201503720A 2015-03-05 2015-03-05 Chemical compound Ceased GB201503720D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB201503720A GB201503720D0 (en) 2015-03-05 2015-03-05 Chemical compound
TW105106561A TW201704230A (en) 2015-03-05 2016-03-03 Chemical compound
PCT/EP2016/054516 WO2016139292A1 (en) 2015-03-05 2016-03-03 Pyridinone compound, pharmaceutical composition containing the same and use
ARP160100564A AR103844A1 (en) 2015-03-05 2016-03-03 CHEMICAL COMPOUND
UY0001036574A UY36574A (en) 2015-03-05 2016-03-03 BROMODOMINIUM INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201503720A GB201503720D0 (en) 2015-03-05 2015-03-05 Chemical compound

Publications (1)

Publication Number Publication Date
GB201503720D0 true GB201503720D0 (en) 2015-04-22

Family

ID=52998420

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201503720A Ceased GB201503720D0 (en) 2015-03-05 2015-03-05 Chemical compound

Country Status (5)

Country Link
AR (1) AR103844A1 (en)
GB (1) GB201503720D0 (en)
TW (1) TW201704230A (en)
UY (1) UY36574A (en)
WO (1) WO2016139292A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018527340A (en) 2015-08-11 2018-09-20 ネオメド インスティテュートＮｅｏｍｅｄ Ｉｎｓｔｉｔｕｔｅ Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals
WO2017024406A1 (en) 2015-08-11 2017-02-16 Neomed Institute N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals
KR20180039669A (en) 2015-08-12 2018-04-18 네오메드 인스티튜트 Substituted benzimidazoles, methods for their preparation and their use as pharmaceuticals
WO2017066876A1 (en) 2015-10-21 2017-04-27 Neomed Institute Substituted imidazopyridines, their preparation and their use as pharmaceuticals
WO2017127930A1 (en) 2016-01-28 2017-08-03 Neomed Institute Substituted [1,2,4]triazolo[4,3-a]pyridines, their preparation and their use as pharmaceuticals
CN109280046B (en) * 2017-07-21 2021-02-02 浙江海正药业股份有限公司 Benzimidazole derivative, preparation method thereof and application thereof in medicine
CN109384784B (en) * 2017-08-10 2021-01-12 浙江海正药业股份有限公司 Sulfonamide derivative, preparation method thereof and application thereof in medicine
WO2020219168A1 (en) * 2019-04-24 2020-10-29 Convergene, Llc Small molecule bromodomain inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
AR058289A1 (en) 2005-12-12 2008-01-30 Glaxo Group Ltd COLLECTOR TO BE USED IN MEDICINAL DISPENSER
GB0919434D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
WO2013097052A1 (en) * 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
US20150051208A1 (en) * 2013-08-14 2015-02-19 Boehringer Ingelheim International Gmbh Pyridinones

Also Published As

Publication number Publication date
UY36574A (en) 2016-09-30
WO2016139292A1 (en) 2016-09-09
AR103844A1 (en) 2017-06-07
TW201704230A (en) 2017-02-01

Similar Documents

Publication Publication Date Title
GB201504689D0 (en) Chemical compounds
GB201609602D0 (en) Chemical compounds
GB201604681D0 (en) Chemical Compounds
GB201604680D0 (en) Chemical Compounds
GB201604589D0 (en) Chemical compound
GB201503720D0 (en) Chemical compound
GB201508747D0 (en) Compounds
HK1255832A1 (en) Pyranodipyridine compound
GB201614934D0 (en) Chemical compounds
GB201501025D0 (en) Chemical compounds
GB201521524D0 (en) Compound
GB201520500D0 (en) Compounds
GB201602527D0 (en) Chemical compounds
GB201520419D0 (en) Compounds
GB201512286D0 (en) Chemical compounds
GB201614940D0 (en) Chemical compounds
GB201518950D0 (en) Compound
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
HK1251574A1 (en) Tetrahydrooxepinopyridine compound
GB201613262D0 (en) Chemical compound
GB201613264D0 (en) Chemical compound
GB201622002D0 (en) Chemical compounds
ZA201607136B (en) Chemical compounds
GB201519316D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)